CHSCN
CHS Inc.
CHSCN lost money over the past year, so it has no meaningful PE right now.
CHSCN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Healthy |
CHSCN's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
CHSCN PE Valuation
CHSCN has no meaningful PE right now: it lost money over the past year.
CHSCN Forward outlook
There aren't enough analyst estimates for CHSCN to show an outlook.
CHSCN Earnings Per Share
CHSCN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.4B | +21% |
| Q2 2026 | $11.6B | +19% |
| Q1 2026 | $8.4B | +7.2% |
| Q4 2025 | $8.9B | -4.6% |
| Q3 2025 | $8.6B | -6.2% |
| Q2 2025 | $9.8B | +1.6% |
| Q1 2025 | $7.8B | -14% |
| Q4 2024 | $9.3B | -18% |
CHSCN's revenue is recovering but still below its 2022 peak: $10.4B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +5.2 points |
| Q2 2026 | 0.9% | +0.2 points |
| Q1 2026 | -2.9% | -0.7 points |
| Q4 2025 | 1.4% | -0.1 points |
| Q3 2025 | 0.6% | +0.9 points |
| Q2 2025 | 0.7% | -0.9 points |
| Q1 2025 | -2.2% | -3 points |
| Q4 2024 | 1.5% | -2 points |
CHSCN's operating margin was 5.8% last quarter, up 5.2 points from the same quarter a year ago, near the top of its range since 2019.
CHSCN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +17% |
| Q2 2026 | $984.7M | +89% |
| Q1 2026 | -$674M | +$528.8M |
| Q4 2025 | -$453.8M | +$32.8M |
| Q3 2025 | $1.1B | +27% |
| Q2 2025 | $520.6M | +44% |
| Q1 2025 | -$1.2B | -$749.5M |
| Q4 2024 | -$486.6M | -$196.6M |
CHSCN's free cash flow has turned positive after two years mostly in the red: $1.1B over the past year.
CHSCN Total Shares
CHSCN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 1.9x | Healthy |
| Q3 2025 | 2.0x | Moderate |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 2.7x | Moderate |
| Q4 2024 | 2.1x | Moderate |
CHSCN's net debt is about 1.4 years of its operating earnings (EBITDA), down from 2.0 years a year ago.
CHSCN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 20.2 | Oversold |
| Stochastic | 9.9 | Oversold |
CHSCN's weekly RSI is 20 (oversold) and its Stochastic is 10 (oversold).
CHSCN PE vs Consumer Defensive Sector
CHSCN has no meaningful PE right now: it lost money over the past year.
CHSCN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.6 | 6.5% below |
| 20 week MA | $24.5 | 9.9% below |
| 50 week MA | $24.9 | 12% below |
| 100 week MA | $25.1 | 12% below |
| 200 week MA | $25.3 | 13% below |
CHSCN is in a downtrend: it's below all five of its weekly moving averages, and 13% below its 200-week average.
CHSCN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.0 | $27.8 | +2.9% |
| 2021 | $27.8 | $27.5 | -1% |
| 2022 | $27.5 | $24.7 | -10% |
| 2023 | $24.7 | $25.0 | +1.3% |
| 2024 | $25.0 | $25.0 | +0.2% |
| 2025 | $25.0 | $24.9 | -0.5% |
| 2026 YTD | $24.9 | $22.1 | -11% |
CHSCN has finished lower in three of the last six years. It's down 11% so far in 2026.